A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195 - PubMed (original) (raw)
A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195
Alexander N Anderson et al. Neuroimage. 2007.
Abstract
[(11)C]-(R)-PK11195 is presently the most widely used radiotracer for the monitoring of microglia activity in the central nervous system (CNS). Microglia, the resident immune cells of the brain, play a critical role in acute and chronic diseases of the central nervous system and in host defence against neoplasia. The purpose of this investigation was to evaluate the reliability and sensitivity of five kinetic modelling methods for the formation of parametric maps from dynamic [(11)C]-(R)-PK11195 studies. The methods we tested were the simplified reference tissue model (SRTM), basis pursuit, a simple target-to-reference ratio, the Logan plot and a wavelet based Logan plot. For the reliability assessment, the test-retest data consisted of four Alzheimer's patients that were scanned twice at approximately a six-week interval. For the sensitivity assessment, comparison of [(11)C]-(R)-PK11195 binding in Huntington's disease (HD) patients and normal subjects was performed using a group contrast to localize significant increases in mean pixel volume of distribution (VD) in HD. In all instances, a reference region kinetic extracted by a supervised clustering technique was used as input function. Reliability was assessed by use of the intra-class correlation coefficient (ICC) across a wide set of anatomical regions and it was found that the wavelet-based Logan plot, basis pursuit and SRTM gave the highest ICC values on average. The same methods produced the highest z-scores resulting from increases in mean striatal VD in HD patients compared with controls. The reference-to-target ratio and the Logan graphical approach were significantly less reliable and less sensitive.
Similar articles
- Evaluation of methods for generating parametric (R-[11C]PK11195 binding images.
Schuitemaker A, van Berckel BN, Kropholler MA, Kloet RW, Jonker C, Scheltens P, Lammertsma AA, Boellaard R. Schuitemaker A, et al. J Cereb Blood Flow Metab. 2007 Sep;27(9):1603-15. doi: 10.1038/sj.jcbfm.9600459. Epub 2007 Feb 21. J Cereb Blood Flow Metab. 2007. PMID: 17311080 - Reference and target region modeling of [11C]-(R)-PK11195 brain studies.
Turkheimer FE, Edison P, Pavese N, Roncaroli F, Anderson AN, Hammers A, Gerhard A, Hinz R, Tai YF, Brooks DJ. Turkheimer FE, et al. J Nucl Med. 2007 Jan;48(1):158-67. J Nucl Med. 2007. PMID: 17204713 - Global-two-stage filtering of clinical PET parametric maps: application to [(11)C]-(R)-PK11195.
Tomasi G, Bertoldo A, Cobelli C, Pavese N, Tai YF, Hammers A, Turkheimer FE. Tomasi G, et al. Neuroimage. 2011 Apr 1;55(3):942-53. doi: 10.1016/j.neuroimage.2010.12.056. Epub 2010 Dec 30. Neuroimage. 2011. PMID: 21195193 - Imaging microglial activation in Huntington's disease.
Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P. Tai YF, et al. Brain Res Bull. 2007 Apr 30;72(2-3):148-51. doi: 10.1016/j.brainresbull.2006.10.029. Epub 2006 Nov 27. Brain Res Bull. 2007. PMID: 17352938 Review. - Visualising microglial activation in vivo.
Banati RB. Banati RB. Glia. 2002 Nov;40(2):206-217. doi: 10.1002/glia.10144. Glia. 2002. PMID: 12379908 Review.
Cited by
- Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies.
Chauveau F, Becker G, Boutin H. Chauveau F, et al. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):201-220. doi: 10.1007/s00259-021-05425-w. Epub 2021 Aug 13. Eur J Nucl Med Mol Imaging. 2021. PMID: 34387719 Free PMC article. Review. - Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.
Kang Y, Schlyer D, Kaunzner UW, Kuceyeski A, Kothari PJ, Gauthier SA. Kang Y, et al. PLoS One. 2018 Aug 9;13(8):e0201289. doi: 10.1371/journal.pone.0201289. eCollection 2018. PLoS One. 2018. PMID: 30091993 Free PMC article. - [11C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy.
Passamonti L, Rodríguez PV, Hong YT, Allinson KSJ, Bevan-Jones WR, Williamson D, Jones PS, Arnold R, Borchert RJ, Surendranathan A, Mak E, Su L, Fryer TD, Aigbirhio FI, O'Brien JT, Rowe JB. Passamonti L, et al. Neurology. 2018 May 29;90(22):e1989-e1996. doi: 10.1212/WNL.0000000000005610. Epub 2018 Apr 27. Neurology. 2018. PMID: 29703774 Free PMC article. - In vivo PET imaging of neuroinflammation in Alzheimer's disease.
Lagarde J, Sarazin M, Bottlaender M. Lagarde J, et al. J Neural Transm (Vienna). 2018 May;125(5):847-867. doi: 10.1007/s00702-017-1731-x. Epub 2017 May 17. J Neural Transm (Vienna). 2018. PMID: 28516240 Review. - Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging.
Cerami C, Iaccarino L, Perani D. Cerami C, et al. Int J Mol Sci. 2017 May 5;18(5):993. doi: 10.3390/ijms18050993. Int J Mol Sci. 2017. PMID: 28475165 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- G108/585/MRC_/Medical Research Council/United Kingdom
- G84/6523/MRC_/Medical Research Council/United Kingdom
- MC_U120036861/MRC_/Medical Research Council/United Kingdom
- MC_U120085814/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Medical